Login to Your Account



Continental shift

Newco Andes Bio moves to U.S. seeking more financing options

By Oliver Griffin
Contributing Writer

Monday, June 12, 2017

BUENOS AIRES, Argentina – Andes Biotechnologies SA, a cancer drug company from Santiago, Chile, is planning to cement its presence in the U.S. as it begins to emerge from stealth mode.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription